|
|
Post by sportsrancho on Jun 7, 2018 14:50:04 GMT -5
I personally am assuming it is...I bought shares on purpose just to trade it. I won’t be selling any of my long-time shares though.
They had this price target out there for a while they just reaffirmed it today.
|
|
|
|
Post by mytakeonit on Jun 7, 2018 14:55:58 GMT -5
 Selling at $5-6 and "hope" to get back in at a lower price??? Two theories come to mind ... Trying to catch a runaway train. Shudda, Cudda, Wudda. |
|
|
|
Post by veritasfiliatemporis on Jun 7, 2018 14:59:23 GMT -5
Didn’t we give Sanofi first right of refusal for a GLP-1 product when we partnered with them for Afrezza? I believe we completely severed ties with Sanofi when we settled with them a couple of years ago. At this point, we have no ties to Sanofi. It was the best thing that could have happened to get away from that back stabbing, lying company. They almost killed MannKind off. Sanofi they still have the right to cry... but it's too late |
|
|
|
Post by boca1girl on Jun 7, 2018 15:12:43 GMT -5
Selling at $5-6 and "hope" to get back in at a lower price??? Two theories come to mind ... Trying to catch a runaway train. Shudda, Cudda, Wudda. Reminds me of the Back to the Future movies. Wish we could see a news paper (with stock quotes) with a date of 10/01/18. I still have shares with a cost basis over $25 so I wouln’t see there being too much risk of the runaway train scenario with those shares. |
|
|
|
Post by mytakeonit on Jun 7, 2018 15:37:19 GMT -5
I have a couple hundred shares over $50 that were $10 shares before the reverse split.
Which brings to mind all this talk about dilution. If I remember correctly, MNKD was at 600M shares and did the reverse split. Seems to me this opens up a major source of $$$ to keep it up and running since we authorized ?? 280M shares? Everything seems to be starting now and the runway is looking exciting !!!
|
|
|
|
Post by kc on Jun 7, 2018 18:47:33 GMT -5
While I was at the corporate website's pipeline page downloading the graphic, I branched out and did a little more exploration of the R&D webpages. This is an interesting little nugget I dug up:
Diverse Compatibility
Our dry powder formulation technology is compatible with a diverse assortment of drugs over a broad range of physicochemical characteristics, including molecular weight (300 – 150,000 Daltons), structure (small molecules to monoclonal antibodies), charge, and hydrophilicity/hydrophobicity. Our dry powders are ideally suited to deliver drugs for local diseases, such asthma and COPD.
In addition, the use of our Technosphere technology for systemic conditions was validated by the FDA approval of AFREZZA® (insulin human) inhalation powder, and has also been demonstrated in clinical studies with Technosphere formulations of parathyroid hormone (PTH/Technosphere), salmon calcitonin (sCT/Technosphere), and glucagon-like peptide 1 (GLP-1/Technosphere).
Source: www.mannkindcorp.com/research-development/tech-platforms/dry-powder-formulation/
---
I wasn't aware that there were clinical studies conducted for these three API.
I few years ago I wrote that if Afrezza is a golden egg, then Technosphere is the goose that laid it. These studies bolster my opinion that, based on Intellectual Property alone, the stock market has greatly undervalued this company.
 What is this information (clinical studies) that was possibly found in the treasure trove of studies at Dr. Kendall came across? |
|
|
|
Post by rockstarrick on Jun 7, 2018 21:25:51 GMT -5
I have a couple hundred shares over $50 that were $10 shares before the reverse split. Which brings to mind all this talk about dilution. If I remember correctly, MNKD was at 600M shares and did the reverse split. Seems to me this opens up a major source of $$$ to keep it up and running since we authorized ?? 280M shares? Everything seems to be starting now and the runway is looking exciting !!! 450 million before the split ✌🏻😎 |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jun 7, 2018 21:47:24 GMT -5
I am FINALLY starting to feel Matt's "embarrassment of riches" comment. United Tech better pull out their checkbook, price to play ball has started to climb.
|
|
|
|
Post by tomtabb on Jun 7, 2018 22:20:59 GMT -5
Where does Mannkind buy its treprostinil? I assume they have to use some sort of FDA approved pharmaceutical grade version.
|
|
|
|
Post by babaoriley on Jun 7, 2018 22:33:19 GMT -5
Oh, perhaps you weren't aware that Mike and David recruited a bunch of test subjects at the Annual Meeting - shareholders were falling over each other to volunteer!  More importantly, it looks like they have taken a page from our illustrious leader (btw, don't take that too seriously NY Lefty, however, chameleon you can take the analogy serious ) about not telegraphing and using a little bit of the surprise factor, even good ole Spence was caught off guard, which is what I've mentioned before about those darn catalysts that come from left field and aren't or can never really be part of his "modeling". It's happened before and suspect it will happen many more times in the future. Biggest game of the year tonight Baba, win this one and the pressure gets a tad heavier on those red jersey's back in DC. (I would have use the VGK color font in bold but was put in the corner with 20 lashes for overdoing it previously but one can use your imagination, insert pic of hockey stick here Joey, I was rooting for your Knights, but when they lost that second game and were denied that tying goal in the last minute or so by the miracle save, I have to tell you I flashed right back to the 2003 Finals, Kings losing 4 straight to Montreal after stickgate. (Last Canadian team to win the Cup). I can't say I hate the Capitals, it was great that they won after so many years (I know about that!), but the season and the playoff run for the Knights was magical and I'm sure all Vegas fans appreciated the treat their team gave them all season long! Since we're in the same division, I'm sure I'll get to dislike the Knights, but not for now! As I told people when they beat the Kings, the Kings played really well in that series, and still the Knights overcame that with excellent, excellent defense. That was so impressive for a team that I felt was mainly great on offense, but so so on defense. The Caps were able to take their space away, much the way the Knights usually do to their opponents. Hats off to them, no one else was able to do that! So, congrats on a truly fantastic season, may MNKD be so tenacious and gallant! |
|
|
|
Post by bradleysbest on Jun 7, 2018 22:36:53 GMT -5
Well said Baba but it would have been great to see the Knights win it all so the Sports books would have to pay out on those 500-1 pre-season tickets! Oh well great season Joey
|
|
|
|
Post by mytakeonit on Jun 7, 2018 22:56:02 GMT -5
I have a couple hundred shares over $50 that were $10 shares before the reverse split. Which brings to mind all this talk about dilution. If I remember correctly, MNKD was at 600M shares and did the reverse split. Seems to me this opens up a major source of $$$ to keep it up and running since we authorized ?? 280M shares? Everything seems to be starting now and the runway is looking exciting !!! 450 million before the split ✌🏻😎 What? So we were at 90M shares after the split? Who lied to me ... I was ripped off !!! Or was it dementia? Ha! |
|
|
|
Post by peppy on Jun 7, 2018 23:39:36 GMT -5
More importantly, it looks like they have taken a page from our illustrious leader (btw, don't take that too seriously NY Lefty, however, chameleon you can take the analogy serious ) about not telegraphing and using a little bit of the surprise factor, even good ole Spence was caught off guard, which is what I've mentioned before about those darn catalysts that come from left field and aren't or can never really be part of his "modeling". It's happened before and suspect it will happen many more times in the future. Biggest game of the year tonight Baba, win this one and the pressure gets a tad heavier on those red jersey's back in DC. (I would have use the VGK color font in bold but was put in the corner with 20 lashes for overdoing it previously but one can use your imagination, insert pic of hockey stick here Joey, I was rooting for your Knights, but when they lost that second game and were denied that tying goal in the last minute or so by the miracle save, I have to tell you I flashed right back to the 2003 Finals, Kings losing 4 straight to Montreal after stickgate. (Last Canadian team to win the Cup). I can't say I hate the Capitals, it was great that they won after so many years (I know about that!), but the season and the playoff run for the Knights was magical and I'm sure all Vegas fans appreciated the treat their team gave them all season long! Since we're in the same division, I'm sure I'll get to dislike the Knights, but not for now! As I told people when they beat the Kings, the Kings played really well in that series, and still the Knights overcame that with excellent, excellent defense. That was so impressive for a team that I felt was mainly great on offense, but so so on defense. The Caps were able to take their space away, much the way the Knights usually do to their opponents. Hats off to them, no one else was able to do that! So, congrats on a truly fantastic season, may MNKD be so tenacious and gallant! knights, kings and capitals, this is still the stick  |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jun 8, 2018 0:42:52 GMT -5
I am FINALLY starting to feel Matt's "embarrassment of riches" comment. United Tech better pull out their checkbook, price to play ball has started to climb. UT made their decision to back Steadymed. They decided to go with the PATCH & PUMP. $200M dollars worth. Oh well.... Looks like the fight is between Liquidia and Mannkind. |
|
|
|
Post by lakers on Jun 8, 2018 2:50:20 GMT -5
Drug Candidates with 505(b)(2) Potential A company may wish to create a new dosage form that is faster acting, combines two active ingredients in a novel way, or provides a route of administration or mechanism of drug delivery that patients or doctors prefer over previous versions. Also, a company may wish to seek approval for a new indication for an already-approved drug or carry out an Rx-to-OTC switch. Such new products often contain well-understood active ingredients that are present in existing, approved drug products (reference drugs); so, companies must only create a bridge between what is already known about the previously approved reference drug and the novel drug product or indication. The 505(b)(2) NDA pathway makes this possible Benefits of 505(b)(2) 505(b)(2) is particularly valuable for pharmaceutical and generics companies looking to alleviate competitive forces in their environments while still wanting to benefit from a development process that eliminates most nonclinical studies as well as extensive safety and efficacy tests. Relatively low risk because of previous drug approval Lower cost, accelerated development due to fewer studies May qualify for three, five or seven years of market exclusivity camargopharma.com/what-is-505b2/ |
|
Selling at $5-6 and "hope" to get back in at a lower price??? Two theories come to mind ... 
